News
STIM
3.490
-0.85%
-0.030
Weekly Report: what happened at STIM last week (0415-0419)?
Weekly Report · 4d ago
Weekly Report: what happened at STIM last week (0408-0412)?
Weekly Report · 04/15 10:03
Neuronetics, Inc. Announces New Publication In Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Neuronetics, Inc. Published significant clinical findings in Brain Stimulation. Early symptom improvement in major depressive disorder (MDD) is strongly predictive of response at the completion of transcranial magnetic stimulation treatment. Researchers found that lack of early improvement does not predict final treatment outcome. The findings are based on research from the world's largest registry of depression outcomes.
Benzinga · 04/10 12:39
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Neuronetics, Inc. Published significant clinical findings in Brain Stimulation, the premier journal in the field of neuromodulation. Early symptom improvement in major depressive disorder does not predict final treatment outcome. Neuronetics is a medical technology company focused on neurohealth disorders.
Barchart · 04/10 07:31
Weekly Report: what happened at STIM last week (0401-0405)?
Weekly Report · 04/08 10:06
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
NASDAQ · 04/01 14:52
Weekly Report: what happened at STIM last week (0325-0329)?
Weekly Report · 04/01 10:05
Neuronetics Inc Shrinks Board Following Strategy Review
TipRanks · 03/28 20:27
Top 5 Health Care Stocks That May Plunge In March
Five stocks in the health care sector are overbought as of March 28, 2024. The RSI is a momentum indicator that compares a stock's strength on days when prices go up to its weakness. The Pennant Group, Inc. Is one of the five stocks with an RSI value of 90.
Benzinga · 03/28 12:30
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Neuronetics, Inc. Granted inducement awards of 135,000 shares of the Company’s common stock to eleven new non-executive employees. Neuronetics is a commercial stage medical technology company. The company is focused on developing products that improve the quality of life for neurohealth disorders.
Barchart · 03/27 15:30
Buy Rating for Neuronetics Amid FDA Clearance and Expanding Adolescent MDD Market
TipRanks · 03/26 11:16
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Landos Biopharma, Inc. Shares jumped 171.2% to $21.70 on Monday. AbbVie and Landos signed a definitive agreement to acquire the company. Altamira Therapeutics Ltd. Shares climbed 70.1% after falling around 22% on Friday. GameStop Corp. Shares rose 8.4% after the company announced a separation.
Benzinga · 03/25 18:44
Neuronetics Shares Climb 15% After FDA Cleared Depression Treatment for Adolescents Aged 15 to 21
Neuronetics shares are up 15% to $4.85. The company's stock has surged 69% since the beginning of the year. The FDA has cleared its treatment for the treatment of major depressive disorder in adolescent patients aged 15 to 21. About 4.3 million U.S. Adolescents are affected by the disorder.
Dow Jones · 03/25 14:11
Neuronetics gets FDA nod for NeuroStar as add-on treatment for adolescents with depression
Neuronetics gets FDA nod for NeuroStar as add-on treatment for adolescents with depression. The medical technology firm's stock jumped 20% in premarket trading. NeuroStar is a transcranial magnetic stimulation treatment for the treatment of major depressive disorder in adolescents aged 15-21.
Seeking Alpha · 03/25 13:14
12 Health Care Stocks Moving In Monday's Pre-Market Session
Landos Biopharma (NASDAQ:LABP) shares moved upwards by 181.6% to $22.05 during Monday's pre-market session. Altamira Therapeutics shares rose 49.71% after their Q4 earnings report came out yesterday. Neuronetics stock increased by 18.19% in pre- market.
Benzinga · 03/25 13:05
Neuronetics: NeuroStar Advanced Therapy Gets FDA Clearance For New Indication
NASDAQ · 03/25 12:45
Weekly Report: what happened at STIM last week (0318-0322)?
Weekly Report · 03/25 10:07
Weekly Report: what happened at STIM last week (0311-0315)?
Weekly Report · 03/18 10:06
Weekly Report: what happened at STIM last week (0304-0308)?
Weekly Report · 03/11 10:04
Neuronetics (STIM) Progresses in MRD and TRD With New Deal
NASDAQ · 03/08 13:06
More
Webull provides a variety of real-time STIM stock news. You can receive the latest news about Neuronetics through multiple platforms. This information may help you make smarter investment decisions.
About STIM
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.